540 related articles for article (PubMed ID: 26095589)
1. Phosphodiesterase regulation of alcohol drinking in rodents.
Logrip ML
Alcohol; 2015 Dec; 49(8):795-802. PubMed ID: 26095589
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.
Kelly MP
Cell Signal; 2018 Jan; 42():281-291. PubMed ID: 29175000
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
4. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
[TBL] [Abstract][Full Text] [Related]
5. Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence.
Wen RT; Liang JH; Zhang HT
Adv Neurobiol; 2017; 17():413-444. PubMed ID: 28956341
[TBL] [Abstract][Full Text] [Related]
6. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons.
Moon C; Simpson PJ; Tu Y; Cho H; Ronnett GV
J Neurochem; 2005 Oct; 95(1):200-9. PubMed ID: 16181424
[TBL] [Abstract][Full Text] [Related]
7. Differential phosphodiesterase activity contributes to restrictive endothelial barrier function during angiogenesis.
DeFouw LM; DeFouw DO
Microvasc Res; 2001 Nov; 62(3):263-70. PubMed ID: 11678629
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
Eckly-Michel A; Martin V; Lugnier C
Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
[TBL] [Abstract][Full Text] [Related]
11. Development of Phosphodiesterase-Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity.
Tulsian NK; Sin VJ; Koh HL; Anand GS
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063491
[TBL] [Abstract][Full Text] [Related]
12. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
13. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.
Rich TC; Tse TE; Rohan JG; Schaack J; Karpen JW
J Gen Physiol; 2001 Jul; 118(1):63-78. PubMed ID: 11429444
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular genetics of the phosphodiesterases (PDEs).
Azevedo MF; Faucz FR; Bimpaki E; Horvath A; Levy I; de Alexandre RB; Ahmad F; Manganiello V; Stratakis CA
Endocr Rev; 2014 Apr; 35(2):195-233. PubMed ID: 24311737
[TBL] [Abstract][Full Text] [Related]
16. PDE2 at the crossway between cAMP and cGMP signalling in the heart.
Weber S; Zeller M; Guan K; Wunder F; Wagner M; El-Armouche A
Cell Signal; 2017 Oct; 38():76-84. PubMed ID: 28668721
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis between cyclic GMP and cyclic AMP signalling in human sperm.
Willipinski-Stapelfeldt B; Lübberstedt J; Stelter S; Vogt K; Mukhopadhyay AK; Müller D
Mol Hum Reprod; 2004 Jul; 10(7):543-52. PubMed ID: 15121877
[TBL] [Abstract][Full Text] [Related]
18. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
Nishi A; Kuroiwa M; Miller DB; O'Callaghan JP; Bateup HS; Shuto T; Sotogaku N; Fukuda T; Heintz N; Greengard P; Snyder GL
J Neurosci; 2008 Oct; 28(42):10460-71. PubMed ID: 18923023
[TBL] [Abstract][Full Text] [Related]
20. Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation.
Shelly M; Lim BK; Cancedda L; Heilshorn SC; Gao H; Poo MM
Science; 2010 Jan; 327(5965):547-52. PubMed ID: 20110498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
